The power of diversity.

Estimates show that more than 90 percent of the research into the genetics underlying disease has been conducted on people of European ancestry.

Whether this has been due to historical, cultural, economic or social reasons, we believe genetics and the study of disease and drug development should be for everyone. All ethnicities. All humans.

Our customer base includes large numbers of self-identified African Americans, Latinos and Asians. As we increase our understanding of different populations, we can better predict ancestry and perform fine-scale genetic mapping that can also be crucial for detecting associations with disease via admixture mapping.